Chris Orvig, Ph.D. - Publications

Affiliations: 
Chemistry University of British Columbia, Vancouver, Vancouver, BC, Canada 

245 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Kostelnik TI, Scheiber H, Cappai R, Choudhary N, Lindheimer F, Guadalupe Jaraquemada-Peláez M, Orvig C. Phosphonate Chelators for Medicinal Metal Ions. Inorganic Chemistry. PMID 33719399 DOI: 10.1021/acs.inorgchem.1c00290  0.48
2021 Di Y, Wasan EK, Cawthray J, Syeda J, Ali M, Cooper DML, Al-Dissi A, Ashjaee N, Cheng W, Johnston J, Weekes DM, Kostelnik TI, Orvig C, Wasan KM. Evaluation of La(XT), a novel lanthanide compound, in an OVX rat model of osteoporosis. Bone Reports. 14: 100753. PMID 33665236 DOI: 10.1016/j.bonr.2021.100753  0.48
2021 Wharton L, Kurakina E, Radchenko V, Schaffer P, Orvig C. Chemical Promiscuity of Non-Macrocyclic Multidentate Chelating Ligands for Radiometal Ions: Hneunpa-NH Hnoneunpa. Inorganic Chemistry. PMID 33635057 DOI: 10.1021/acs.inorgchem.1c00152  0.6
2021 Southcott L, Wang X, Wharton L, Yang H, Radchenko V, Kubeil M, Stephan H, de Guadalupe Jaraquemada-Peláez M, Orvig C. High denticity oxinate-linear-backbone chelating ligand for diagnostic radiometal ions [In]In and [Zr]Zr. Dalton Transactions (Cambridge, England : 2003). PMID 33629999 DOI: 10.1039/d0dt04230g  0.6
2020 Lu X, Liang H, Orvig C, Chen ZF. Peptide and Small Molecule Inhibitors Targeting Myeloid Cell Leukemia 1 (Mcl-1) as Novel Antitumor Agents. Current Molecular Medicine. PMID 32990536 DOI: 10.2174/1566524020666200929121016  0.72
2020 Ferrier MG, Li Y, Chyan MK, Wong R, Li L, Spreckelmeyer S, Hamlin DK, Mastren T, Fassbender ME, Orvig C, Wilbur DS. Thorium chelators for Targeted Alpha Therapy: Rapid chelation of thorium-226. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 32812275 DOI: 10.1002/jlcr.3875  0.44
2020 Lu X, Liu Y, Orvig C, Liang H, Chen ZF. Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent. Journal of Medicinal Chemistry. PMID 32794745 DOI: 10.1021/acs.jmedchem.9b02047  0.72
2020 Li L, Kuo HT, Wang X, Merkens H, Colpo N, Radchenko V, Schaffer P, Lin KS, Bénard F, Orvig C. Buoctapa-alkyl-NHS for metalloradiopeptide preparation. Dalton Transactions (Cambridge, England : 2003). PMID 32459231 DOI: 10.1039/d0dt00845a  0.6
2020 Li YL, Zhu XM, Liang H, Orvig C, Chen ZF. Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH Responsive Hepatocellular Carcinoma-Targeted Drug Delivery. Current Medicinal Chemistry. PMID 32368967 DOI: 10.2174/0929867327666200505085756  0.72
2020 Kostelnik TI, Wang X, Southcott L, Wagner HK, Kubeil M, Stephan H, Jaraquemada-Peláez MG, Orvig C. Rapid Thermodynamically Stable Complex Formation of [In]In, [Y]Y, and [Lu]Lu with Hdappa. Inorganic Chemistry. PMID 32337985 DOI: 10.1021/acs.inorgchem.0c00671  0.6
2020 Li L, de Guadalupe Jaraquemada-Peláez M, Aluicio-Sarduy E, Wang X, Barnhart TE, Cai W, Radchenko V, Schaffer P, Engle JW, Orvig C. Coordination chemistry of [Y(pypa)] and comparison immuno-PET imaging of [Sc]Sc- and [Y]Y-pypa-phenyl-TRC105. Dalton Transactions (Cambridge, England : 2003). PMID 32270167 DOI: 10.1039/d0dt00437e  0.6
2020 Choudhary N, Guadalupe Jaraquemada-Peláez MA, Zarschler K, Wang X, Radchenko V, Kubeil M, Stephan H, Orvig C. Chelation in One Fell Swoop: Optimizing Ligands for Smaller Radiometal Ions. Inorganic Chemistry. PMID 32242663 DOI: 10.1021/acs.inorgchem.0c00509  0.6
2020 Li L, Rousseau J, Jaraquemada-Peláez MG, Wang X, Robertson A, Radchenko V, Schaffer P, Lin KS, Bénard F, Orvig C. 225Ac-H4py4pa for Targeted-Alpha-Therapy. Bioconjugate Chemistry. PMID 32216377 DOI: 10.1021/acs.bioconjchem.0c00171  0.6
2020 Wang X, Jaraquemada-Peláez MG, Cao Y, Ingham A, Rodríguez-Rodríguez C, Pan J, Wang Y, Saatchi K, Häfeli UO, Lin KS, Orvig C. Hhox: Rigid Cyclohexane-Reinforced Nonmacrocyclic Chelating Ligand for [Ga]Ga. Inorganic Chemistry. PMID 32175726 DOI: 10.1021/acs.inorgchem.0c00168  0.6
2020 Li L, Jaraquemada-Peláez MG, Aluicio-Sarduy E, Wang X, Jiang D, Sakheie M, Kuo HT, Barnhart TE, Cai W, Radchenko V, Schaffer P, Lin KS, Engle JW, Bénard F, Orvig C. [Sc(pypa)]: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate. Inorganic Chemistry. PMID 31976659 DOI: 10.1021/acs.inorgchem.9b03347  0.6
2019 Ramogida CF, Robertson AKH, Jermilova U, Zhang C, Yang H, Kunz P, Lassen J, Bratanovic I, Brown V, Southcott L, Rodríguez-Rodríguez C, Radchenko V, Bénard F, Orvig C, Schaffer P. Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced Ac. Ejnmmi Radiopharmacy and Chemistry. 4: 21. PMID 31659557 DOI: 10.1186/s41181-019-0072-5  0.6
2019 Buchwalder C, Jaraquemada-Peláez MG, Rousseau J, Merkens H, Rodríguez-Rodríguez C, Orvig C, Bénard F, Schaffer P, Saatchi K, Häfeli UO. Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular Zr-THPN-Conjugates. Inorganic Chemistry. PMID 31633347 DOI: 10.1021/acs.inorgchem.9b02350  0.56
2019 Lu X, Liu YC, Orvig C, Liang H, Chen ZF. Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models. European Journal of Medicinal Chemistry. 181: 111567. PMID 31401535 DOI: 10.1016/j.ejmech.2019.111567  0.72
2019 Choudhary N, Dimmling A, Wang X, Southcott L, Radchenko V, Patrick BO, Comba P, Orvig C. Octadentate Oxine-Armed Bispidine Ligand for Radiopharmaceutical Chemistry. Inorganic Chemistry. PMID 31247868 DOI: 10.1021/acs.inorgchem.9b01016  0.76
2019 Li L, Jaraquemada-Peláez MG, Kuo HT, Merkens H, Choudhary N, Gitschalter K, Jermilova U, Colpo N, Uribe-Munoz C, Radchenko V, Schaffer P, Lin KS, Benard F, Orvig C. Functionally Versatile and Highly Stable Chelator for 111In and 177Lu: Proof-of-principle Prostate Specific Membrane Antigen Targeting. Bioconjugate Chemistry. PMID 31009566 DOI: 10.1021/acs.bioconjchem.9b00225  0.6
2018 Khan TM, Gul NS, Lu X, Wei JH, Liu YC, Sun H, Liang H, Orvig C, Chen ZF. In vitro and in vivo anti-tumor activity of two gold(III) complexes with isoquinoline derivatives as ligands. European Journal of Medicinal Chemistry. 163: 333-343. PMID 30529636 DOI: 10.1016/j.ejmech.2018.11.047  0.72
2018 Wang X, Jaraquemada-Peláez MG, Rodríguez-Rodríguez C, Cao Y, Buchwalder C, Choudhary N, Jermilova U, Ramogida CF, Saatchi K, Häfeli UO, Patrick BO, Orvig C. Hoctox: Versatile Bimodal Octadentate Acyclic Chelating Ligand for Medicinal Inorganic Chemistry. Journal of the American Chemical Society. PMID 30394734 DOI: 10.1021/jacs.8b09964  0.76
2018 Kostelnik TI, Orvig C. Radioactive Main Group and Rare Earth Metals for Imaging and Therapy. Chemical Reviews. PMID 30379537 DOI: 10.1021/acs.chemrev.8b00294  0.48
2018 Wang X, Jaraquemada-Peláez MG, Cao Y, Pan J, Lin KS, Patrick BO, Orvig C. Hhox: Dual-Channel Oxine-Derived Acyclic Chelating Ligand for Ga Radiopharmaceuticals. Inorganic Chemistry. PMID 29989801 DOI: 10.1021/acs.inorgchem.8b01208  0.76
2017 Cao Y, Wang X, Shi X, Clee SM, McGeer PL, Wolf MO, Orvig C. Biological Imaging with Medium-Sensitive Bichromatic Flexible Fluorescent (FlexFluor) Dyes. Angewandte Chemie (International Ed. in English). PMID 29045760 DOI: 10.1002/anie.201708529  0.6
2017 Chen ZF, Orvig C, Liang H. Multi-Target Metal-Based Anticancer Agents. Current Topics in Medicinal Chemistry. PMID 28982336 DOI: 10.2174/1568026617666171004155437  0.72
2017 Jaraquemada-Peláez MG, Wang X, Clough TJ, Cao Y, Choudhary N, Emler K, Patrick BO, Orvig C. H4octapa: synthesis, solution equilibria and complexes with useful radiopharmaceutical metal ions. Dalton Transactions (Cambridge, England : 2003). PMID 28853751 DOI: 10.1039/c7dt02343j  0.76
2017 Comba P, Jermilova U, Orvig C, Patrick BO, Ramogida CF, Rück K, Schneider C, Starke M. Octadentate picolinic acid-based bispidine ligand for radiometal ions. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 28815804 DOI: 10.1002/chem.201702284  0.76
2017 Song B, Storr T, Liu S, Orvig C. Retraction of "Synthesis and Solution Studies of the Complexes of Trivalent Lanthanides with the Tetraazamacrocycle TETA-(PO)2". Inorganic Chemistry. PMID 28806876 DOI: 10.1021/acs.inorgchem.7b01932  0.76
2017 Weekes DM, Jaraquemada-Peláez MG, Kostelnik TI, Patrick BO, Orvig C. Di- and Trivalent Metal-Ion Solution Studies with the Phosphinate-Containing Heterocycle DEDA-(PO). Inorganic Chemistry. PMID 28806872 DOI: 10.1021/acs.inorgchem.7b01117  0.76
2017 Wehbe M, Leung AWY, Abrams MJ, Orvig C, Bally MB. A Perspective - can copper complexes be developed as a novel class of therapeutics? Dalton Transactions (Cambridge, England : 2003). PMID 28702645 DOI: 10.1039/c7dt01955f  0.32
2017 Spreckelmeyer S, Ramogida CF, Rousseau J, Arane K, Bratanovic I, Colpo N, Jermilova U, Dias G, Dude I, Jaraquemada Peláez MG, Benard F, Schaffer P, Orvig C. p-NO2-Bn-H4neunpa and H4neunpa-Trastuzumab: Bifunctional Chelator for Radiometalpharmaceuticals and 111In Immuno-SPECT Imaging. Bioconjugate Chemistry. PMID 28683198 DOI: 10.1021/acs.bioconjchem.7b00311  0.48
2016 Weekes DM, Ramogida CF, Jaraquemada-Peláez MG, Patrick BO, Apte C, Kostelnik TI, Cawthray JF, Murphy L, Orvig C. Dipicolinate Complexes of Gallium(III) and Lanthanum(III). Inorganic Chemistry. 55: 12544-12558. PMID 27989179 DOI: 10.1021/acs.inorgchem.6b02357  0.76
2016 Price EW, Edwards KJ, Carnazza KE, Carlin SD, Zeglis BM, Adam MJ, Orvig C, Lewis JS. A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y. Nuclear Medicine and Biology. 43: 566-576. PMID 27419360 DOI: 10.1016/j.nucmedbio.2016.06.004  1
2016 Mjos KD, Cawthray JF, Polishchuk E, Abrams MJ, Orvig C. Gallium(iii) and iron(iii) complexes of quinolone antimicrobials. Dalton Transactions (Cambridge, England : 2003). PMID 27315225 DOI: 10.1039/c6dt01315e  0.6
2016 Ramogida CF, Boros E, Patrick BO, Zeisler SK, Kumlin J, Adam MJ, Schaffer P, Orvig C. Evaluation of H2CHXdedpa, H2dedpa- and H2CHXdedpa-N,N'-propyl-2-NI ligands for (64)Cu(ii) radiopharmaceuticals. Dalton Transactions (Cambridge, England : 2003). PMID 27161975 DOI: 10.1039/c6dt00932h  0.76
2016 Mjos KD, Polishchuk E, Abrams MJ, Orvig C. Synthesis, characterization, and evaluation of the antimicrobial potential of copper(II) coordination complexes with quinolone and p-xylenyl-linked quinolone ligands. Journal of Inorganic Biochemistry. PMID 26979255 DOI: 10.1016/j.jinorgbio.2016.02.026  0.32
2016 Abrams MJ, Kronauge J, Lister-James J, Mahmood A, Nicholson T, Orvig C. Alan Davison, FRS. Nuclear Medicine and Biology. 43: 189-90. PMID 26924498 DOI: 10.1016/j.nucmedbio.2015.11.006  0.32
2016 Telpoukhovskaia MA, Patrick BO, Rodríguez-Rodríguez C, Orvig C. In silico to in vitro screening of hydroxypyridinones as acetylcholinesterase inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 26869193 DOI: 10.1016/j.bmcl.2016.01.080  1
2015 Ramogida CF, Murphy L, Cawthray JF, Ross JD, Adam MJ, Orvig C. Novel "bi-modal" H2dedpa derivatives for radio- and fluorescence imaging. Journal of Inorganic Biochemistry. PMID 26652124 DOI: 10.1016/j.jinorgbio.2015.11.021  1
2015 Telpoukhovskaia MA, Cawthray JF, Rodríguez-Rodríguez C, Scott LE, Page BD, Patrick BO, Orvig C. 3-Hydroxy-4-pyridinone derivatives designed for fluorescence studies to determine interaction with amyloid protein as well as cell permeability. Bioorganic & Medicinal Chemistry Letters. 25: 3654-7. PMID 26141772 DOI: 10.1016/j.bmcl.2015.06.059  0.76
2015 Bertrand B, Spreckelmeyer S, Bodio E, Cocco F, Picquet M, Richard P, Le Gendre P, Orvig C, Cinellu MA, Casini A. Exploring the potential of gold(iii) cyclometallated compounds as cytotoxic agents: variations on the C^N theme. Dalton Transactions (Cambridge, England : 2003). 44: 11911-8. PMID 26060937 DOI: 10.1039/c5dt01023c  1
2015 Ramogida CF, Pan J, Ferreira CL, Patrick BO, Rebullar K, Yapp DT, Lin KS, Adam MJ, Orvig C. Nitroimidazole-Containing H2dedpa and H2CHXdedpa Derivatives as Potential PET Imaging Agents of Hypoxia with (68)Ga. Inorganic Chemistry. 54: 4953-65. PMID 25928800 DOI: 10.1021/acs.inorgchem.5b00554  1
2015 Ramogida CF, Cawthray JF, Boros E, Ferreira CL, Patrick BO, Adam MJ, Orvig C. H2CHXdedpa and H4CHXoctapa-chiral acyclic chelating ligands for (67/68)Ga and (111)In radiopharmaceuticals. Inorganic Chemistry. 54: 2017-31. PMID 25621728 DOI: 10.1021/ic502942a  1
2015 Cawthray JF, Creagh AL, Haynes CA, Orvig C. Ion exchange in hydroxyapatite with lanthanides. Inorganic Chemistry. 54: 1440-5. PMID 25594577 DOI: 10.1021/ic502425e  1
2015 Mjos KD, Cawthray JF, Jamieson G, Fox JA, Orvig C. Iron(III)-binding of the anticancer agents doxorubicin and vosaroxin. Dalton Transactions (Cambridge, England : 2003). 44: 2348-58. PMID 25534904 DOI: 10.1039/c4dt02934h  1
2015 Rodríguez-Rodríguez C, Telpoukhovskaia MA, Alí-Torres J, Rodríguez-Santiago L, Manso Y, Bailey GA, Hidalgo J, Sodupe M, Orvig C. Thioflavin-based molecular probes for application in Alzheimer's disease: from in silico to in vitro models. Metallomics : Integrated Biometal Science. 7: 83-92. PMID 25325557 DOI: 10.1039/c4mt00167b  1
2015 Cawthray JF, Weekes DM, Sivak O, Creagh AL, Ibrahim F, Iafrate M, Haynes CA, Wasan KM, Orvig C. In vivo study and thermodynamic investigation of two lanthanum complexes, La(dpp)3 and La(XT), for the treatment of bone resorption disorders Chemical Science. 6: 6439-6447. DOI: 10.1039/c5sc01767j  1
2015 Telpoukhovskaia MA, Cawthray JF, Rodríguez-Rodríguez C, Scott LE, Page BDG, Patrick BO, Orvig C. 3-Hydroxy-4-pyridinone derivatives designed for fluorescence studies to determine interaction with amyloid protein as well as cell permeability Bioorganic and Medicinal Chemistry Letters. DOI: 10.1016/j.bmcl.2015.06.059  1
2014 Spreckelmeyer S, Orvig C, Casini A. Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin. Molecules (Basel, Switzerland). 19: 15584-610. PMID 25268716 DOI: 10.3390/molecules191015584  1
2014 Price EW, Zeglis BM, Cawthray JF, Lewis JS, Adam MJ, Orvig C. What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry. Inorganic Chemistry. 53: 10412-31. PMID 25192223 DOI: 10.1021/ic501466z  1
2014 Price EW, Cawthray JF, Adam MJ, Orvig C. Modular syntheses of H₄octapa and H₂dedpa, and yttrium coordination chemistry relevant to ⁸⁶Y/⁹⁰Y radiopharmaceuticals. Dalton Transactions (Cambridge, England : 2003). 43: 7176-90. PMID 24676528 DOI: 10.1039/c4dt00239c  1
2014 Mjos KD, Orvig C. Metallodrugs in medicinal inorganic chemistry. Chemical Reviews. 114: 4540-63. PMID 24456146 DOI: 10.1021/cr400460s  1
2014 Telpoukhovskaia MA, Rodríguez-Rodríguez C, Scott LE, Page BD, Patrick BO, Orvig C. Synthesis, characterization, and cytotoxicity studies of Cu(II), Zn(II), and Fe(III) complexes of N-derivatized 3-hydroxy-4-pyridiones. Journal of Inorganic Biochemistry. 132: 59-66. PMID 24393377 DOI: 10.1016/j.jinorgbio.2013.12.003  1
2014 Mawani Y, Orvig C. Improved separation of the curcuminoids, syntheses of their rare earth complexes, and studies of potential antiosteoporotic activity. Journal of Inorganic Biochemistry. 132: 52-8. PMID 24387940 DOI: 10.1016/j.jinorgbio.2013.12.004  1
2014 Price EW, Orvig C. Matching chelators to radiometals for radiopharmaceuticals. Chemical Society Reviews. 43: 260-90. PMID 24173525 DOI: 10.1039/c3cs60304k  1
2014 Price EW, Zeglis BM, Lewis JS, Adam MJ, Orvig C. H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu. Dalton Transactions (Cambridge, England : 2003). 43: 119-31. PMID 24104523 DOI: 10.1039/c3dt51940f  1
2014 Telpoukhovskaia MA, Rodríguez-Rodríguez C, Cawthray JF, Scott LE, Page BD, Alí-Torres J, Sodupe M, Bailey GA, Patrick BO, Orvig C. 3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents. Metallomics : Integrated Biometal Science. 6: 249-62. PMID 23999879 DOI: 10.1039/c3mt00135k  1
2014 Price EW, Ferreira CL, Adam MJ, Orvig C. High-denticity ligands based on picolinic acid for 111In radiochemistry Canadian Journal of Chemistry. 92: 695-705. DOI: 10.1139/cjc-2013-0542  1
2014 Price EW, Orvig C. The Chemistry of Inorganic Nuclides (86Y, 68Ga, 64Cu, 89Zr, 124I) The Chemistry of Molecular Imaging. 105-135. DOI: 10.1002/9781118854754.ch5  1
2013 Dikanov SA, Liboiron BD, Orvig C. VO(2+)-hydroxyapatite complexes as models for vanadyl coordination to phosphate in bone. Molecular Physics. 111: 2967-2979. PMID 24829511 DOI: 10.1080/00268976.2013.796412  1
2013 Price EW, Zeglis BM, Cawthray JF, Ramogida CF, Ramos N, Lewis JS, Adam MJ, Orvig C. H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy. Journal of the American Chemical Society. 135: 12707-21. PMID 23901833 DOI: 10.1021/ja4049493  1
2013 Ramogida CF, Orvig C. Tumour targeting with radiometals for diagnosis and therapy. Chemical Communications (Cambridge, England). 49: 4720-39. PMID 23599005 DOI: 10.1039/c3cc41554f  1
2013 Telpoukhovskaia MA, Patrick BO, Rodríguez-Rodríguez C, Orvig C. Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease. Molecular Biosystems. 9: 792-805. PMID 23435553 DOI: 10.1039/c3mb25600f  1
2013 Salas PF, Herrmann C, Orvig C. Metalloantimalarials. Chemical Reviews. 113: 3450-92. PMID 23425067 DOI: 10.1021/cr3001252  1
2013 Salas PF, Herrmann C, Cawthray JF, Nimphius C, Kenkel A, Chen J, de Kock C, Smith PJ, Patrick BO, Adam MJ, Orvig C. Structural characteristics of chloroquine-bridged ferrocenophane analogues of ferroquine may obviate malaria drug-resistance mechanisms. Journal of Medicinal Chemistry. 56: 1596-613. PMID 23327489 DOI: 10.1021/jm301422h  1
2013 Mawani Y, Cawthray JF, Chang S, Sachs-Barrable K, Weekes DM, Wasan KM, Orvig C. In vitro studies of lanthanide complexes for the treatment of osteoporosis. Dalton Transactions (Cambridge, England : 2003). 42: 5999-6011. PMID 23299719 DOI: 10.1039/c2dt32373g  1
2013 Telpoukhovskaia MA, Orvig C. Werner coordination chemistry and neurodegeneration. Chemical Society Reviews. 42: 1836-46. PMID 22952002 DOI: 10.1039/c2cs35236b  1
2012 Bailey GA, Price EW, Zeglis BM, Ferreira CL, Boros E, Lacasse MJ, Patrick BO, Lewis JS, Adam MJ, Orvig C. H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu. Inorganic Chemistry. 51: 12575-89. PMID 23106422 DOI: 10.1021/ic302225z  1
2012 Boros E, Cawthray JF, Ferreira CL, Patrick BO, Adam MJ, Orvig C. Evaluation of the H2)dedpa scaffold and its cRGDyK conjugates for labeling with 64Cu. Inorganic Chemistry. 51: 6279-84. PMID 22583103 DOI: 10.1021/ic300482x  1
2012 Price EW, Cawthray JF, Bailey GA, Ferreira CL, Boros E, Adam MJ, Orvig C. H4octapa: an acyclic chelator for 111In radiopharmaceuticals. Journal of the American Chemical Society. 134: 8670-83. PMID 22540281 DOI: 10.1021/ja3024725  1
2012 Boros E, Ferreira CL, Yapp DT, Gill RK, Price EW, Adam MJ, Orvig C. RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga. Nuclear Medicine and Biology. 39: 785-94. PMID 22381779 DOI: 10.1016/j.nucmedbio.2012.01.003  1
2012 Herrmann C, Salas PF, Patrick BO, de Kock C, Smith PJ, Adam MJ, Orvig C. 1,2-disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarial agents. Dalton Transactions (Cambridge, England : 2003). 41: 6431-42. PMID 22378031 DOI: 10.1039/c2dt12050j  1
2012 Herrmann C, Salas PF, Patrick BO, Kock CD, Smith PJ, Adam MJ, Orvig C. Modular synthesis of 1,2- and 1,1′-disubstituted ferrocenyl carbohydrate chloroquine and mefloquine conjugates as potential antimalarial agents Organometallics. 31: 5748-5759. DOI: 10.1021/om300392q  1
2012 Herrmann C, Salas PF, Cawthray JF, De Kock C, Patrick BO, Smith PJ, Adam MJ, Orvig C. 1,1′-disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarials Organometallics. 31: 5736-5747. DOI: 10.1021/om300354x  1
2012 Esparza-Ruiz A, Herrmann C, Chen J, Patrick BO, Polishchuk E, Orvig C. Synthesis and in vitro anticancer activity of ferrocenyl-aminoquinoline- carboxamide conjugates Inorganica Chimica Acta. 393: 276-283. DOI: 10.1016/j.ica.2012.06.039  1
2012 Rodríguez-Rodríguez C, Telpoukhovskaia M, Orvig C. The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases Coordination Chemistry Reviews. 256: 2308-2332. DOI: 10.1016/j.ccr.2012.03.008  1
2011 Boros E, Ferreira CL, Patrick BO, Adam MJ, Orvig C. New Ga derivatives of the H2dedpa scaffold with improved clearance and persistent heart uptake. Nuclear Medicine and Biology. 38: 1165-74. PMID 21831655 DOI: 10.1016/j.nucmedbio.2011.05.004  1
2011 Boros E, Lin YH, Ferreira CL, Patrick BO, Häfeli UO, Adam MJ, Orvig C. One to chelate them all: investigation of a versatile, bifunctional chelator for 64Cu, 99mTc, Re and Co. Dalton Transactions (Cambridge, England : 2003). 40: 6253-9. PMID 21308135 DOI: 10.1039/c0dt01458c  1
2011 Scott LE, Telpoukhovskaia M, Rodríguez-Rodríguez C, Merkel M, Bowen ML, Page BDG, Green DE, Storr T, Thomas F, Allen DD, Lockman PR, Patrick BO, Adamd MJ, Orvig C. N-Aryl-substituted 3-(b-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy Chemical Science. 2: 642-648. DOI: 10.1039/c0sc00544d  1
2011 Mawani Y, Orvig C. Essential Metal Related Metabolic Disorders Bioinorganic Medicinal Chemistry. 307-350. DOI: 10.1002/9783527633104.ch11  1
2010 Boros E, Ferreira CL, Cawthray JF, Price EW, Patrick BO, Wester DW, Adam MJ, Orvig C. Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration. Journal of the American Chemical Society. 132: 15726-33. PMID 20958034 DOI: 10.1021/ja106399h  1
2010 Ferreira CL, Marques FL, Okamoto MR, Otake AH, Sugai Y, Mikata Y, Storr T, Bowen M, Yano S, Adam MJ, Chammas R, Orvig C. Cationic technetium and rhenium complexes with pendant carbohydrates. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 68: 1087-93. PMID 20153207 DOI: 10.1016/j.apradiso.2010.01.033  1
2010 Green DE, Bowen ML, Scott LE, Storr T, Merkel M, Böhmerle K, Thompson KH, Patrick BO, Schugar HJ, Orvig C. In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. Dalton Transactions (Cambridge, England : 2003). 39: 1604-15. PMID 20104324 DOI: 10.1039/b918439b  1
2010 Saha B, Orvig C. Biosorbents for hexavalent chromium elimination from industrial and municipal effluents Coordination Chemistry Reviews. 254: 2959-2972. DOI: 10.1016/j.ccr.2010.06.005  1
2009 Bowen ML, Chen ZF, Roos AM, Misri R, Häfeli U, Adam MJ, Orvig C. Long-chain rhenium and technetium glucosamine conjugates. Dalton Transactions (Cambridge, England : 2003). 9228-36. PMID 20449200 DOI: 10.1039/b914309b  1
2009 Bowen ML, Lim NC, Ewart CB, Misri R, Ferreira CL, Häfeli U, Adam MJ, Orvig C. Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc). Dalton Transactions (Cambridge, England : 2003). 9216-27. PMID 20449199 DOI: 10.1039/b914310f  1
2009 Chen ZF, Tan MX, Liu LM, Liu YC, Wang HS, Yang B, Peng Y, Liu HG, Liang H, Orvig C. Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry. Dalton Transactions (Cambridge, England : 2003). 10824-33. PMID 20023912 DOI: 10.1039/b910133k  1
2009 Liu YC, Chen ZF, Liu LM, Peng Y, Hong X, Yang B, Liu HG, Liang H, Orvig C. Divalent later transition metal complexes of the traditional chinese medicine (TCM) liriodenine: coordination chemistry, cytotoxicity and DNA binding studies. Dalton Transactions (Cambridge, England : 2003). 10813-23. PMID 20023911 DOI: 10.1039/b912553a  1
2009 Scott LE, Orvig C. Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. Chemical Reviews. 109: 4885-910. PMID 19637926 DOI: 10.1021/cr9000176  1
2009 Storr T, Scott LE, Bowen ML, Green DE, Thompson KH, Schugar HJ, Orvig C. Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy. Dalton Transactions (Cambridge, England : 2003). 3034-43. PMID 19352532 DOI: 10.1039/b902545f  1
2009 Boros E, Häfeli UO, Patrick BO, Adam MJ, Orvig C. Design, synthesis, and imaging of small amphiphilic rhenium and (99m)technetium tricarbonyl complexes. Bioconjugate Chemistry. 20: 1002-9. PMID 19341277 DOI: 10.1021/bc900022c  1
2009 Thompson KH, Lichter J, LeBel C, Scaife MC, McNeill JH, Orvig C. Vanadium treatment of type 2 diabetes: a view to the future. Journal of Inorganic Biochemistry. 103: 554-8. PMID 19162329 DOI: 10.1016/j.jinorgbio.2008.12.003  1
2009 Chen ZF, Liu YC, Liu LM, Wang HS, Qin SH, Wang BL, Bian HD, Yang B, Fun HK, Liu HG, Liang H, Orvig C. Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies. Dalton Transactions (Cambridge, England : 2003). 262-72. PMID 19089006 DOI: 10.1039/b813363h  1
2009 Bordbar AK, Creagh AL, Mohammadi F, Haynes CA, Orvig C. Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin. Journal of Inorganic Biochemistry. 103: 643-7. PMID 19056126 DOI: 10.1016/j.jinorgbio.2008.10.009  1
2009 Orvig C, Humphrey J. 2008: A record year for Dalton Transactions! Dalton Transactions. 15-17. DOI: 10.1039/b820347b  1
2009 Lever ABP, Orvig C, Reedijk J. Stan Kirschner-An appreciation Coordination Chemistry Reviews. 253: 1970-1972. DOI: 10.1016/j.ccr.2008.12.015  1
2008 Scott LE, Page BD, Patrick BO, Orvig C. Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease. Dalton Transactions (Cambridge, England : 2003). 6364-7. PMID 19002321 DOI: 10.1039/b815404j  1
2008 Bowen ML, Orvig C. 99m-Technetium carbohydrate conjugates as potential agents in molecular imaging. Chemical Communications (Cambridge, England). 5077-91. PMID 18956031 DOI: 10.1039/b809365b  1
2008 Humphrey J, Orvig C. Dalton transactions: providing the best services. Dalton Transactions (Cambridge, England : 2003). 15-7. PMID 18399219 DOI: 10.1039/b717247h  1
2008 Zhang YA, Monga V, Orvig C, Wang YA. Theoretical studies of the tautomers of pyridinethiones. The Journal of Physical Chemistry. A. 112: 3231-8. PMID 18341304 DOI: 10.1021/jp0744026  1
2008 Barta CA, Bayly SR, Read PW, Patrick BO, Thompson RC, Orvig C. Molecular architectures for trimetallic d/f/d complexes: structural and magnetic properties of a LnNi2 core. Inorganic Chemistry. 47: 2280-93. PMID 18318481 DOI: 10.1021/ic701612e  1
2008 Barta CA, Bayly SR, Read PW, Patrick BO, Thompson RC, Orvig C. Molecular architectures for trimetallic d/f/d complexes: magnetic studies of a LnCu2 core. Inorganic Chemistry. 47: 2294-302. PMID 18318480 DOI: 10.1021/ic701613x  1
2008 Lim NC, Ewart CB, Bowen ML, Ferreira CL, Barta CA, Adam MJ, Orvig C. Pyridine-tert-nitrogen-phenol ligands: N,N,O-Type tripodal chelates for the [M(CO)3]+ core (M = Re, Tc). Inorganic Chemistry. 47: 1337-45. PMID 18189350 DOI: 10.1021/ic701822n  1
2008 Orvig C. Orvig's marvellous medicine Chemistry World. 5: 31.  1
2007 Barta CA, Sachs-Barrable K, Jia J, Thompson KH, Wasan KM, Orvig C. Lanthanide containing compounds for therapeutic care in bone resorption disorders. Dalton Transactions (Cambridge, England : 2003). 5019-30. PMID 17992287 DOI: 10.1039/b705123a  1
2007 Ferreira CL, Lapi S, Steele J, Green DE, Ruth TJ, Adam MJ, Orvig C. 55Cobalt complexes with pendant carbohydrates as potential PET imaging agents. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 65: 1303-8. PMID 17666190 DOI: 10.1016/j.apradiso.2007.06.003  1
2007 Storr T, Merkel M, Song-Zhao GX, Scott LE, Green DE, Bowen ML, Thompson KH, Patrick BO, Schugar HJ, Orvig C. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. Journal of the American Chemical Society. 129: 7453-63. PMID 17511455 DOI: 10.1021/ja068965r  1
2007 Schugar H, Green DE, Bowen ML, Scott LE, Storr T, Böhmerle K, Thomas F, Allen DD, Lockman PR, Merkel M, Thompson KH, Orvig C. Combating Alzheimer's disease with multifunctional molecules designed for metal passivation. Angewandte Chemie (International Ed. in English). 46: 1716-8. PMID 17397084 DOI: 10.1002/anie.200603866  1
2006 Thompson KH, Orvig C. Vanadium in diabetes: 100 years from Phase 0 to Phase I. Journal of Inorganic Biochemistry. 100: 1925-35. PMID 17055061 DOI: 10.1016/j.jinorgbio.2006.08.016  1
2006 Ferreira CL, Ewart CB, Barta CA, Little S, Yardley V, Martins C, Polishchuk E, Smith PJ, Moss JR, Merkel M, Adam MJ, Orvig C. Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates. Inorganic Chemistry. 45: 8414-22. PMID 16999442 DOI: 10.1021/ic061166p  1
2006 Ferreira CL, Bayly SR, Green DE, Storr T, Barta CA, Steele J, Adam MJ, Orvig C. Carbohydrate-appended 3-hydroxy-4-pyridinone complexes of the [M(CO)3]+ core (M = Re, 99mTc, 186Re). Bioconjugate Chemistry. 17: 1321-9. PMID 16984143 DOI: 10.1021/bc060085e  1
2006 Ferreira CL, Ewart CB, Bayly SR, Patrick BO, Steele J, Adam MJ, Orvig C. Glucosamine conjugates of tricarbonylcyclopentadienyl rhenium(I) and technetium(I) cores. Inorganic Chemistry. 45: 6979-87. PMID 16903757 DOI: 10.1021/ic0605672  1
2006 Thompson KH, Barta CA, Orvig C. Metal complexes of maltol and close analogues in medicinal inorganic chemistry. Chemical Society Reviews. 35: 545-56. PMID 16729148 DOI: 10.1039/b416256k  1
2006 Storr T, Thompson KH, Orvig C. Design of targeting ligands in medicinal inorganic chemistry. Chemical Society Reviews. 35: 534-44. PMID 16729147 DOI: 10.1039/b514859f  1
2006 Thompson KH, Orvig C. Editorial: lanthanide compounds for therapeutic and diagnostic applications. Chemical Society Reviews. 35: 499. PMID 16729143 DOI: 10.1039/b606622b  1
2006 Thompson KH, Orvig C. Metal complexes in medicinal chemistry: new vistas and challenges in drug design. Dalton Transactions (Cambridge, England : 2003). 761-4. PMID 16437168 DOI: 10.1039/b513476e  1
2006 Kovacs MS, Monga V, Patrick BO, Orvig C. Lanthanide(III) and group 13 metal ion complexes of tripodal amino phosphinate ligands. Dalton Transactions (Cambridge, England : 2003). 31-8. PMID 16357958 DOI: 10.1039/b507905e  1
2005 Green DE, Ferreira CL, Stick RV, Patrick BO, Adam MJ, Orvig C. Carbohydrate-bearing 3-hydroxy-4-pyridinonato complexes of gallium(III) and indium(III). Bioconjugate Chemistry. 16: 1597-609. PMID 16287260 DOI: 10.1021/bc0501808  1
2005 Mohammadi K, Thompson KH, Patrick BO, Storr T, Martins C, Polishchuk E, Yuen VG, McNeill JH, Orvig C. Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. Journal of Inorganic Biochemistry. 99: 2217-25. PMID 16171869 DOI: 10.1016/j.jinorgbio.2005.08.001  1
2005 Saatchi K, Patrick BO, Orvig C. Coordination chemistry of P, O-bidentate phosphinophenolates with Ga3+ and In3+. Dalton Transactions (Cambridge, England : 2003). 2268-74. PMID 15962047 DOI: 10.1039/b501908g  1
2005 Nakai M, Sekiguchi F, Obata M, Ohtsuki C, Adachi Y, Sakurai H, Orvig C, Rehder D, Yano S. Synthesis and insulin-mimetic activities of metal complexes with 3-hydroxypyridine-2-carboxylic acid. Journal of Inorganic Biochemistry. 99: 1275-82. PMID 15917081 DOI: 10.1016/j.jinorgbio.2005.02.026  1
2005 Storr T, Sugai Y, Barta CA, Mikata Y, Adam MJ, Yano S, Orvig C. Carbohydrate-appended 2,2'-dipicolylamine metal complexes as potential imaging agents. Inorganic Chemistry. 44: 2698-705. PMID 15819555 DOI: 10.1021/ic048528i  1
2005 Saatchi K, Thompson KH, Patrick BO, Pink M, Yuen VG, McNeill JH, Orvig C. Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers. Inorganic Chemistry. 44: 2689-97. PMID 15819554 DOI: 10.1021/ic048186g  1
2005 Monga V, Thompson KH, Yuen VG, Sharma V, Patrick BO, McNeill JH, Orvig C. Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies. Inorganic Chemistry. 44: 2678-88. PMID 15819553 DOI: 10.1021/ic0486926  1
2005 Monga V, Patrick BO, Orvig C. Group 13 and lanthanide complexes with mixed O,S anionic ligands derived from maltol. Inorganic Chemistry. 44: 2666-77. PMID 15819552 DOI: 10.1021/ic048693y  1
2005 Liboiron BD, Thompson KH, Hanson GR, Lam E, Aebischer N, Orvig C. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals. Journal of the American Chemical Society. 127: 5104-15. PMID 15810845 DOI: 10.1021/ja043944n  1
2005 Storr T, Fisher CL, Mikata Y, Yano S, Adam MJ, Orvig C. A glucosamine-dipicolylamine conjugate of 99mTc(I) and 186Re(I) for use in imaging and therapy. Dalton Transactions (Cambridge, England : 2003). 654-5. PMID 15702173 DOI: 10.1039/b416040a  1
2004 Thompson KH, Böhmerle K, Polishchuk E, Martins C, Toleikis P, Tse J, Yuen V, McNeill JH, Orvig C. Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone. Journal of Inorganic Biochemistry. 98: 2063-70. PMID 15541495 DOI: 10.1016/j.jinorgbio.2004.09.011  1
2004 Storr T, Obata M, Fisher CL, Bayly SR, Green DE, Brudziñska I, Mikata Y, Patrick BO, Adam MJ, Yano S, Orvig C. Novel carbohydrate-appended metal complexes for potential use in molecular imaging. Chemistry (Weinheim An Der Bergstrasse, Germany). 11: 195-203. PMID 15540259 DOI: 10.1002/chem.200400719  1
2004 Bayly SR, Fisher CL, Storr T, Adam MJ, Orvig C. Carbohydrate conjugates for molecular imaging and radiotherapy: 99mTc(I) and 186Re(I) tricarbonyl complexes of N-(2'-Hydroxybenzyl)-2-amino-2-deoxy-D-glucose. Bioconjugate Chemistry. 15: 923-6. PMID 15264883 DOI: 10.1021/bc0499681  1
2004 Thompson KH, Orvig C. Vanadium compounds in the treatment of diabetes. Metal Ions in Biological Systems. 41: 221-52. PMID 15206118  1
2004 Thompson KH, Chiles J, Yuen VG, Tse J, McNeill JH, Orvig C. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes. Journal of Inorganic Biochemistry. 98: 683-90. PMID 15134913 DOI: 10.1016/j.jinorgbio.2004.01.006  1
2004 Nakai M, Obata M, Sekiguchi F, Kato M, Shiro M, Ichimura A, Kinoshita I, Mikuriya M, Inohara T, Kawabe K, Sakurai H, Orvig C, Yano S. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid. Journal of Inorganic Biochemistry. 98: 105-12. PMID 14659639 DOI: 10.1016/j.jinorgbio.2003.09.005  1
2003 Dikanov SA, Liboiron BD, Thompson KH, Vera E, Yuen VG, McNeill JH, Orvig C. One and two dimensional pulsed electron paramagnetic resonance studies of in vivo vanadyl coordination in rat kidney. Bioinorganic Chemistry and Applications. 69-83. PMID 18365044 DOI: 10.1155/S1565363303000062  1
2003 Yuen VG, Bhanot S, Battell ML, Orvig C, McNeill JH. Chronic glucose-lowering effects of rosiglitazone and bis(ethylmaltolato)oxovanadium(IV) in ZDF rats. Canadian Journal of Physiology and Pharmacology. 81: 1049-55. PMID 14719040 DOI: 10.1139/y03-094  1
2003 Thompson KH, Orvig C. Boon and bane of metal ions in medicine. Science (New York, N.Y.). 300: 936-9. PMID 12738851 DOI: 10.1126/science.1083004  1
2003 Bayly SR, Xu Z, Patrick BO, Rettig SJ, Pink M, Thompson RC, Orvig C. Dlf complexes with uniform coordination geometry: structural and magnetic properties of an LnNi2 core supported by a heptadentate amine phenol ligand. Inorganic Chemistry. 42: 1576-83. PMID 12611525 DOI: 10.1021/ic0205278  1
2003 Storr T, Mitchell D, Buglyó P, Thompson KH, Yuen VG, McNeill JH, Orvig C. Vanadyl-thiazolidinedione combination agents for diabetes therapy. Bioconjugate Chemistry. 14: 212-21. PMID 12526711 DOI: 10.1021/bc025606m  1
2003 Thompson KH, Liboiron BD, Sun Y, Bellman KD, Setyawati IA, Patrick BO, Karunaratne V, Rawji G, Wheeler J, Sutton K, Bhanot S, Cassidy C, McNeill JH, Yuen VG, Orvig C. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 8: 66-74. PMID 12459900 DOI: 10.1007/s00775-002-0388-5  1
2002 Song B, Storr T, Liu S, Orvig C. Synthesis and Solution Studies of the Complexes of Trivalent Lanthanides with the Tetraazamacrocycle TETA-(PO)2. Inorganic Chemistry. 41: 685-692. PMID 28806869 DOI: 10.1021/ic010716a  0.76
2002 Thompson KH, Tsukada Y, Xu Z, Battell M, McNeill JH, Orvig C. Influence of chelation and oxidation state on vanadium bioavailability, and their effects on tissue concentrations of zinc, copper, and iron. Biological Trace Element Research. 86: 31-44. PMID 12002658 DOI: 10.1385/BTER:86:1:31  1
2002 Semiz S, Orvig C, McNeill JH. Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats. Molecular and Cellular Biochemistry. 231: 23-35. PMID 11952162 DOI: 10.1023/A:1014437019586  1
2002 Dikanov SA, Liboiron BD, Orvig C. Two-dimensional (2D) pulsed electron paramagnetic resonance study of VO(2+)-triphosphate interactions: evidence for tridentate triphosphate coordination, and relevance to bone uptake and insulin enhancement by vanadium pharmaceuticals. Journal of the American Chemical Society. 124: 2969-78. PMID 11902888 DOI: 10.1021/ja011104s  1
2002 Song B, Aebischer N, Orvig C. Reduction of [VO2(ma)2]- and [VO2(ema)2]- by ascorbic acid and glutathione: kinetic studies of pro-drugs for the enhancement of insulin action. Inorganic Chemistry. 41: 1357-64. PMID 11896702 DOI: 10.1021/ic0111684  1
2002 Song B, Storr T, Liu S, Orvig C. Synthesis and solution studies of the complexes of trivalent lanthanides with the tetraazamacrocycle TETA-(PO)(2). Inorganic Chemistry. 41: 685-92. PMID 11849067 DOI: 10.1021/ic010716a  1
2002 Song B, Saatchi K, Rawji GH, Orvig C. Synthesis and solution studies of the complexes of pyrone analogue ligands with vanadium(IV) and vanadium(V) Inorganica Chimica Acta. 339: 393-399. DOI: 10.1016/S0020-1693(02)00961-1  1
2002 Kovacs MS, Hein P, Sattarzadeh S, Patrick BO, Emge TJ, Orvig C. Complexes of phosphine-phenolate ligands with the [Re=O]3+ and [Re(HNNC5H4N)(NNC5H4N)]2+ cores Journal of the Chemical Society. Dalton Transactions. 3015-3024.  1
2002 Yano S, Nakai M, Sekiguchi F, Obata M, Kato M, Shiro M, Kinoshita I, Mikuriya M, Sakurai H, Orvig C. Mononuclear to tetranuclear structural transformation in vanadyl complexes of 3-hydroxypyridine-2-carboxylic acid (H2hpic) Chemistry Letters. 916-917.  1
2001 Mikata Y, Shinohara Y, Yoneda K, Nakamura Y, Brudziñska I, Tanase T, Kitayama T, Takagi R, Okamoto T, Kinoshita I, Doe M, Orvig C, Yano S. Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-diamminedichloroplatinum(II) complexes. Bioorganic & Medicinal Chemistry Letters. 11: 3045-7. PMID 11714607 DOI: 10.1016/S0960-894X(01)00623-0  1
2001 Melchior M, Rettig SJ, Liboiron BD, Thompson KH, Yuen VG, McNeill JH, Orvig C. Insulin-enhancing vanadium(III) complexes. Inorganic Chemistry. 40: 4686-90. PMID 11511216 DOI: 10.1021/ic000984t  1
2001 Xu L, Lowe MP, Rettig SJ, Orvig C. [ReO(N2O2)X] complexes: "4 + 1"? Inorganic Chemistry. 40: 4623-6. PMID 11511207 DOI: 10.1021/ic001416g  1
2001 Xu L, Rettig SJ, Orvig C. Lanthanide chemistry with (bis[[bis(carboxymethyl)amino]methyl]phosphinate: what does an extra phosphinate group do to EDTA? Inorganic Chemistry. 40: 3734-8. PMID 11442371 DOI: 10.1021/ic0014179  1
2001 Mikata Y, Shinohara Y, Yoneda K, Nakamura Y, Esaki K, Tanahashi M, Brudziñska I, Hirohara S, Yokoyama M, Mogami K, Tanase T, Kitayama T, Takashiba K, Nabeshima K, Takagi R, ... ... Orvig C, et al. Sugar-pendant diamines. The Journal of Organic Chemistry. 66: 3783-9. PMID 11374998 DOI: 10.1021/jo001702+  1
2001 Xu L, Pierreroy J, Patrick BO, Orvig C. Chemistry of re with N,N'-bis(2-pyridylmethyl)ethylenediamine (H2pmen): hydrolysis, dehydrogenation, and ternary complexes. Inorganic Chemistry. 40: 2005-10. PMID 11304142 DOI: 10.1021/ic0013025  1
2001 Song B, Reuber J, Ochs C, Hahn FE, Lügger T, Orvig C. Effects of sequential replacement of -NH2 by -OH in the tripodal tetraamine tren on its acidity and metal ion coordinating properties. Inorganic Chemistry. 40: 1527-35. PMID 11261960 DOI: 10.1021/ic0009831  1
2001 Song B, Kurokawa GS, Liu S, Orvig C. Proton- and lanthanide-coordinating properties of the tetraaza macrocycle (EDDA-KA)2 in aqueous solution Canadian Journal of Chemistry. 79: 1058-1067. DOI: 10.1139/cjc-79-5-6-1058  1
2001 Thompson KH, Orvig C. Coordination chemistry of vanadium in metallopharmaceutical candidate compounds Coordination Chemistry Reviews. 219: 1033-1053. DOI: 10.1016/S0010-8545(01)00395-2  1
2001 Kovacs MS, Hein P, Sattarzadeh S, Patrick BO, Emge TJ, Orvig C. Complexes of phosphine-phenolate ligands with the [Re=O]3+ and [Re(HNNC5H4N)(NNC5H4N)] 2+ cores Journal of the Chemical Society, Dalton Transactions. 3015-3024.  1
2000 Xu Z, Read PW, Hibbs DE, Hursthouse MB, Abdul Malik KM, Patrick BO, Rettig SJ, Seid M, Summers DA, Pink M, Thompson RC, Orvig C. Coaggregation of paramagnetic d- and f-block metal ions with a podand-framework amine phenol ligand. Inorganic Chemistry. 39: 508-16. PMID 11229570 DOI: 10.1021/ic991171b  1
2000 Setyawati IA, Liu S, Rettig SJ, Orvig C. Homotrinuclear lanthanide(III) arrays: assembly of and conversion from mononuclear and dinuclear units. Inorganic Chemistry. 39: 496-507. PMID 11229569 DOI: 10.1021/ic991170j  1
2000 Xu L, Setyawati IA, Pierreroy J, Pink M, Young VG, Patrick BO, Rettig SJ, Orvig C. Seven-coordinate [ReVON4X2]+ complexes (X = O and Cl). Inorganic Chemistry. 39: 5958-63. PMID 11188520 DOI: 10.1021/ic001273y  1
2000 Thompson KH, Orvig C. Design of vanadium compounds as insulin enhancing agents Journal of the Chemical Society, Dalton Transactions. 2885-2892. DOI: 10.1039/b002753g  1
2000 Song B, Mehrkliodavandi P, Buglyo P, Mikata Y, Shinohara Y, Yoneda K, Yano S, Orvig C. Acid-base and metal ion-binding properties of diaminopropyl D-glucopyranoside and diaminopropyl D-mannopyranoside compounds in aqueous solution Journal of the Chemical Society, Dalton Transactions. 1325-1333. DOI: 10.1039/a908384g  1
2000 Hein P, Lügger T, Hahn FE, Rettig SJ, Orvig C. Crystal structure of (2-hydroxy-5-methylphenyl)diphenylphosphineoxide, (C6H5)2P(O)(CH3C6H 3OH) Zeitschrift Fur Kristallographie - New Crystal Structures. 215: 237-238.  1
1999 Thompson KH, McNeill JH, Orvig C. Vanadium compounds as insulin mimics. Chemical Reviews. 99: 2561-72. PMID 11749492  1
1999 Orvig C, Abrams MJ. Medicinal inorganic chemistry: introduction. Chemical Reviews. 99: 2201-4. PMID 11749478  1
1999 Woo LC, Yuen VG, Thompson KH, McNeill JH, Orvig C. Vanadyl-biguanide complexes as potential synergistic insulin mimics. Journal of Inorganic Biochemistry. 76: 251-7. PMID 10605840  1
1999 Dikanov SA, Liboiron BD, Thompson KH, Vera E, Yuen VG, McNeill JH, Orvig C. In vivo electron spin-echo envelope modulation (ESEEM) spectroscopy: First observation of vanadyl coordination to phosphate in bone [2] Journal of the American Chemical Society. 121: 11004-11005. DOI: 10.1021/ja991567m  1
1999 Melchior M, Thompson KH, Jong JM, Rettig SJ, Shuter E, Yuen VG, Zhou Y, McNeill JH, Orvig C. Vanadium complexes as insulin mimetic agents: Coordination chemistry and in vivo studies of oxovanadium(IV) and dioxovanadate(V) complexes formed from naturally occurring chelating oxazolinate, thiazolinate, or picolinate units 1 Inorganic Chemistry. 38: 2288-2293.  1
1999 Yano S, Shinohara Y, Mogami K, Yokoyama M, Tanase T, Sakakibara T, Nishida F, Mochida K, Kinoshita I, Doe M, Ichihara K, Naruta Y, Mehrkhodavandi P, Buglyó P, Song B, ... Orvig C, et al. General synthesis of useful chelating reagents having a sugar unit, 1,3-diamino-2-propyl β-D-glucopyranoside and 1,3-diamino-2-propyl α-D-mannopyranoside Chemistry Letters. 255-256.  1
1999 Setyawati IA, Rettig SJ, Orvig C. Cationic iron(III) complex with a hexadentate N2,N'2,O2- aminopyridylphenolate ligand Canadian Journal of Chemistry. 77: 2033-2038.  1
1998 Thaler F, Hubbard CD, Heinemann FW, van Eldik R, Schindler S, Fábián I, Dittler-Klingemann AM, Hahn FE, Orvig C. Structural, Spectroscopic, Thermodynamic and Kinetic Properties of Copper(II) Complexes with Tripodal Tetraamines. Inorganic Chemistry. 37: 4022-4029. PMID 11670519  1
1998 Bondy SC, Tseng H, Orvig C. Active oxygen species formation in synaptosomes exposed to an aluminum chelator. Neurotoxicology and Teratology. 20: 317-20. PMID 9638689 DOI: 10.1016/S0892-0362(97)00103-7  1
1998 Setyawati IA, Thompson KH, Yuen VG, Sun Y, Battell M, Lyster DM, Vo C, Ruth TJ, Zeisler S, McNeill JH, Orvig C. Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats. Journal of Applied Physiology (Bethesda, Md. : 1985). 84: 569-75. PMID 9475867  1
1998 Hoveyda HR, Karunaratne V, Nichols CJ, Rettig SJ, Stephens AKW, Orvig C. Tripodal trisamides based on nicotinic and picolinic acid derivatives Canadian Journal of Chemistry. 76: 414-425.  1
1998 Van Sun, Melchior M, Summers DA, Thompson RC, Rettig SJ, Orvig C. [μ-OCH3VO(ma)]2, a Strongly Antiferromagnetic Oxovanadium(IV) Dimer Inorganic Chemistry. 37: 3119-3121.  1
1998 Thompson KH, Yuen VG, McNeill JH, Orvig C. Chemical and Pharmacological Studies of a New Class of Antidiabetic Vanadium Complexes Acs Symposium Series. 711: 329-343.  1
1998 Lowe MP, Caravan P, Rettig SJ, Orvig C. Tightening the Hydrophobic Belt: Effects of Backbone and Donor Group Variation on Podand Ligand Complexes of the Lanthanides Inorganic Chemistry. 37: 1637-1647.  1
1998 Stephens AKW, Orvig C. Complexation of Ni2+ and Cu2+ by tripodal amine phenol ligands in aqueous solution Journal of the Chemical Society - Dalton Transactions. 3049-3056.  1
1998 Stephens AKW, Orvig C. Complexation of gallium (III) by 2-hydroxynicotinic acid and 3-hydroxypicolinic acid in aqueous solution Inorganica Chimica Acta. 273: 47-53.  1
1997 Caravan P, Rettig SJ, Orvig C. Effect of Pyridyl Donors in the Chelation of Aluminum(III), Gallium(III), and Indium(III). Inorganic Chemistry. 36: 4912. PMID 11670178  1
1997 Caravan P, Mehrkhodavandi P, Orvig C. Cationic Lanthanide Complexes of N,N'-Bis(2-pyridylmethyl)ethylenediamine-N,N'-diacetic Acid (H(2)bped). Inorganic Chemistry. 36: 1316-1321. PMID 11669707  1
1997 Caravan P, Rettig SJ, Orvig C. Effect of Pyridyl Donors in the Chelation of Aluminum(III), Gallium(III), and Indium(III). Inorganic Chemistry. 36: 1306-1315. PMID 11669706  1
1997 Yuen VG, Caravan P, Gelmini L, Glover N, McNeill JH, Setyawati IA, Zhou Y, Orvig C. Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands. Journal of Inorganic Biochemistry. 68: 109-16. PMID 9336969 DOI: 10.1016/S0162-0134(97)00082-2  1
1997 Schönholzer KW, Sutton RA, Walker VR, Sossi V, Schulzer M, Orvig C, Venczel E, Johnson RR, Vetterli D, Dittrich-Hannen B, Kubik P, Suter M. Intestinal absorption of trace amounts of aluminium in rats studied with 26aluminium and accelerator mass spectrometry. Clinical Science (London, England : 1979). 92: 379-83. PMID 9176037  1
1997 Yuen VG, Orvig C, McNeill JH. Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats. The American Journal of Physiology. 272: E30-5. PMID 9038848  1
1997 Caravan P, Orvig C. Tripodal Aminophenolate Ligand Complexes of Aluminum(III), Gallium(III), and Indium(III) in Water Inorganic Chemistry. 36: 236-248.  1
1997 Caravan P, Mehrkhodavandi P, Orvig C. Cationic Lanthanide Complexes of N,N′-Bis(2-pyridylmethyl)ethylenediamine-N,N′-diacetic Acid (H2bped) Inorganic Chemistry. 36: 1316-1321.  1
1997 Caravan P, Lowe MP, Read PW, Rettig SJ, Yang LW, Orvig C. Selectivity among, and aggregation of, lanthanide ions Journal of Alloys and Compounds. 249: 49-51.  1
1996 Hanson GR, Sun Y, Orvig C. Characterization of the Potent Insulin Mimetic Agent Bis(maltolato)oxovanadium(IV) (BMOV) in Solution by EPR Spectroscopy. Inorganic Chemistry. 35: 6507-6512. PMID 11666798  1
1996 Sun Y, James BR, Rettig SJ, Orvig C. Oxidation Kinetics of the Potent Insulin Mimetic Agent Bis(maltolato)oxovanadium(IV) (BMOV) in Water and in Methanol. Inorganic Chemistry. 35: 1667-1673. PMID 11666389 DOI: 10.1021/ic951452t  1
1996 Shuter E, Hoveyda HR, Karunaratne V, Rettig SJ, Orvig C. Bis(ligand) Rhenium(V) and Technetium(V) Complexes of Two Naturally Occurring Binding Moieties (Oxazoline and Thiazoline). Inorganic Chemistry. 35: 368-372. PMID 11666217  1
1996 Yuen VG, Pederson RA, Dai S, Orvig C, McNeill JH. Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats. Canadian Journal of Physiology and Pharmacology. 74: 1001-9. PMID 8960391 DOI: 10.1139/cjpp-74-9-1001  1
1996 Harris WR, Berthon G, Day JP, Exley C, Flaten TP, Forbes WF, Kiss T, Orvig C, Zatta PF. Speciation of aluminum in biological systems. Journal of Toxicology and Environmental Health. 48: 543-68. PMID 8772798 DOI: 10.1080/009841096161069  1
1996 Luo H, Orvig C, Rettig SJ. trans-tetrachlorobis(triphenylphosphine-P)-rhenium(IV)-mer-trans- Trichlorooxobis(triphenylphosphine-P)rhenium(V) (0.86/0.14) Acta Crystallographica Section C: Crystal Structure Communications. 52: 1377-1380. DOI: 10.1107/S0108270196001710  1
1996 Lowe MP, Rettig SJ, Orvig C. Highly symmetric group 13 metal-phospinato complexes: Multinuclear NMR (27Al, 31P, 71Ga) determination of stability constants at low pH Journal of the American Chemical Society. 118: 10446-10456. DOI: 10.1021/ja961633+  1
1996 Dittler-Klingemann AM, Orvig C, Hahn FE, Thaler F, Hubbard CD, Van Eldik R, Schindler S, Fábián I. Geometric Factors in the Structural and Thermodynamic Properties of Copper(II) Complexes with Tripodal Tetraamines Inorganic Chemistry. 35: 7798-7803.  1
1996 Wong E, Caravan P, Liu S, Rettig SJ, Orvig C. Selectivity of Potentially Hexadentate Amine Phenols for Ga3+ and In3+ in Aqueous Solution Inorganic Chemistry. 35: 715-724.  1
1996 Luo H, Orvig C. Rhenium complexes of P,P,P′,P′-tetrakis (o-hydroxyphenyl)diphosphinoethane Canadian Journal of Chemistry. 74: 722-729.  1
1996 Dittler-Klingemann AM, Hahn FE, Orvig C, Rettig SJ. (Acetonitrile)[N,N-bis(3-aminopropyl)-1,3-propanediamine-N,N′, N″,N‴]copper(II) diperchlorate Acta Crystallographica Section C: Crystal Structure Communications. 52: 1957-1959.  1
1995 McNeill JH, Yuen VG, Dai S, Orvig C. Increased potency of vanadium using organic ligands. Molecular and Cellular Biochemistry. 153: 175-80. PMID 8927036 DOI: 10.1007/BF01075935  1
1995 Orvig C, Thompson KH, Battell M, McNeill JH. Vanadium compounds as insulin mimics. Metal Ions in Biological Systems. 31: 575-94. PMID 8564818  1
1995 Allen DD, Orvig C, Yokel RA. Evidence for energy-dependent transport of aluminum out of brain extracellular fluid. Toxicology. 98: 31-9. PMID 7740551 DOI: 10.1016/0300-483X(94)02953-R  1
1995 Yuen VG, Orvig C, McNeill JH. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Canadian Journal of Physiology and Pharmacology. 73: 55-64. PMID 7600453  1
1995 Caravan P, Gelmini L, Glover N, Geoffrey Herring F, Li H, McNeill JH, Rettig SJ, Setyawati IA, Shuter E, Sun Y, Tracey AS, Yuen VG, Orvig C. Reaction chemistry of BMOV, bis(maltolato)oxovanadium(IV) - A potent insulin mimetic agent Journal of the American Chemical Society. 117: 12759-12770. DOI: 10.1021/ja00156a013  1
1995 Yang LW, Liu S, Wong E, Rettig SJ, Orvig C. Complexes of trivalent metal ions with potentially heptadentate N4O3 Schiff base and amine phenol ligands of varying rigidity Inorganic Chemistry. 34: 2164-2178.  1
1995 Luo H, Setyawati I, Rettig SJ, Orvig C. Rhenium(V) and technetium(V) complexes of bis(o-hydroxyphenyl)phenylphosphine (PO2 2-) and (o-hydroxyphenyl)diphenylphosphine (PO-) ligands Inorganic Chemistry. 34: 2287-2299.  1
1995 Wong E, Liu S, Lügger T, Hahn FE, Orvig C. Hexadentate N4O2 amine phenol complexes of gallium and indium Inorganic Chemistry. 34: 93-101.  1
1995 Wong E, Liu S, Rettig SJ, Orvig C. Gallium and indium complexes of hexadentate ligands containing pendant pyridyl and phenolate groups Inorganic Chemistry. 34: 3057-3064.  1
1995 Yang LW, Liu S, Rettig SJ, Orvig C. Complexation of the potentially heptadentate ligand H3dha3tren with lanthanides: Architecture of a [Nd(NO3)3(H3dha3tren)]n polymer with profuse modes of nitrate coordination Inorganic Chemistry. 34: 4921-4925.  1
1995 Caravan P, Hedlund T, Liu S, Sjöberg S, Orvig C. Potentiometric, calorimetric, and solution NMR studies of a tridentate ligand which has a marked preference for formation of bis(ligand) versus mono(ligand) lanthanide complexes and which exhibits high selectivity for heavier lanthanides Journal of the American Chemical Society. 117: 11230-11238.  1
1994 Allen DD, Orvig C, Yokel RA. Pharmacokinetics and distribution of tris(maltolato)aluminum(III) into the central nervous system. Neurotoxicology. 15: 371-8. PMID 7991226  1
1994 Allen DD, Orvig C, Yokel RA. Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapy. Toxicology. 92: 193-202. PMID 7940560 DOI: 10.1016/0300-483X(94)90177-5  1
1994 Edwards DS, Liu S, Poirier MJ, Zhang Z, Webb GA, Orvig C. Characterization of tris(N-substituted-2-methyl-3-hydroxy-4-pyridinonato)technetium(IV) cations Inorganic Chemistry. 33: 5607-5609.  1
1994 Lutz TG, Clevette DJ, Hoveyda HR, Karunaratne V, Nordin A, Sjoberg S, Winter M, Orvig C. Preparation of 2- and 4-substituted 3-hydroxy-5-methylfurans and the aluminum and gallium complexes of 3-hydroxy-5-methyl-2-(N-methylformamido) furan Canadian Journal of Chemistry. 72: 1362-1369.  1
1993 Yuen VG, Orvig C, Thompson KH, McNeill JH. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV). Canadian Journal of Physiology and Pharmacology. 71: 270-6. PMID 8402391  1
1993 Yuen VG, Orvig C, McNeill JH. Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV). Canadian Journal of Physiology and Pharmacology. 71: 263-9. PMID 8402390  1
1993 Edwards DS, Liu S, Lyster DM, Poirier MJ, Vo C, Webb GA, Zhang Z, Orvig C. Potential 99mTc radiopharmaceuticals for renal imaging: tris(N-substituted-3-hydroxy-2-methyl-4-pyridinonato)technetium(IV) cations. Nuclear Medicine and Biology. 20: 857-63. PMID 8241998 DOI: 10.1016/0969-8051(93)90152-K  1
1993 Luo H, Rettig SJ, Orvig C. Rhenium(V) and technetium(V) complexes of bidentate (O, O) monobasic 3-oxy-4-pyronato and -4-pyridinonato ligands. X-ray structures of cis-bromobis(3-methyl-2-oxy-4-pyronato)oxorhenium(V), tetra-n-butylammonium tribromo(3-methyl-2-oxy-4-pyronato)oxorhenate(V), and tetra-n-butylammomium trichloro(3-methyl-2-oxy-4-pyronato)oxotechnetate(V) Inorganic Chemistry. 32: 4491-4497. DOI: 10.1021/ic00073a005  1
1993 Hoveyda HR, Rettig SJ, Orvig C. Coordination chemistry of 2-(2′-hydroxyphenyl)-2-benzoxazole with gallium(III) and aluminum(III): Two uncommon group 13 metal environments stabilized by a biologically relevant binding group Inorganic Chemistry. 32: 4909-4913.  1
1993 Liu S, Wong E, Rettig SJ, Orvig C. Hexadentate N3O3 amine phenol ligands for group 13 metal ions: Evidence for intrastrand and interstrand hydrogen-bonds in polydentate tripodal amine phenols Inorganic Chemistry. 32: 4268-4276.  1
1993 Liu S, Wong E, Karunaratne V, Rettig SJ, Orvig C. Highly flexible chelating ligands for group 13 metals: Design and synthesis of hexadentate (N3O3) tripodal amine phenol ligand complexes of aluminum, gallium, and indium Inorganic Chemistry. 32: 1756-1765.  1
1993 Liu S, Yang LW, Rettig SJ, Orvig C. Bulky ortho 3-methoxy groups on N4O3 amine phenol ligands producing six-coordinate bis(ligand)lanthanide complex cations [Ln(H3L)2]3+ (Ln = Pr, Gd; H3L = tris(((2-hydroxy-3-methoxybenzyl)amino)ethyl)amine) Inorganic Chemistry. 32: 2773-2778.  1
1993 Dai S, Yuen VG, Orvig C, McNeill JH. Prevention of diabetes-induced pathology in STZ-diabetic rats by bis(maltolato)oxovanadium (IV) Pharmacology Communications. 3: 311-321.  1
1992 Zhang Z, Lyster DM, Webb GA, Orvig C. Potential 67Ga radiopharmaceuticals for myocardial imaging: Tris(1-aryl-3-hydroxy-2-methyl-4-pyridinonato)gallium(III) complexes Nuclear Medicine and Biology. 19: 327-335. PMID 1629022 DOI: 10.1016/0883-2897(92)90118-I  1
1992 McNeill JH, Yuen VG, Hoveyda HR, Orvig C. Bis(maltolato)oxovanadium(IV) is a potent insulin mimic Journal of Medicinal Chemistry. 35: 1489. PMID 1573642 DOI: 10.1021/jm00086a020  1
1992 Kline MA, Orvig C. Complexation of iron with the orally active decorporation drug L1 (3-hydroxy-1,2-dimethyl-4-pyridinone). Clinical Chemistry. 38: 562-5. PMID 1568323  1
1992 Karunaratne V, Hoveyda HR, Orvig C. General method for the synthesis of trishydroxamic acids Tetrahedron Letters. 33: 1827-1830. DOI: 10.1016/S0040-4039(00)74153-0  1
1992 Hoveyda HR, Karunaratne V, Orvig C. Design and synthesis of multidentate 2-(2′-hydroxyphenyl)-2-thiazolines for biomedical application Tetrahedron. 48: 5219-5226. DOI: 10.1016/S0040-4020(01)89019-0  1
1992 Hoveyda HR, Karunaratne V, Rettig SJ, Orvig C. Coordination chemistry of 2-(2′-hydroxyphenyl)-2-oxazolines with aluminum, gallium, and indium: First tris(ligand)metal(III) complexes of this naturally occurring binding group Inorganic Chemistry. 31: 5408-5416.  1
1992 Liu S, Rettig SJ, Orvig C. Polydentate ligand chemistry of group 13 metals: Effects of the size and donor selectivity of metal ions on the structures and properties of aluminum, gallium, and indium complexes with potentially heptadentate (N4O3) amine phenol ligands Inorganic Chemistry. 31: 5400-5407.  1
1992 Liu S, Gelmini L, Rettig SJ, Thompson RC, Orvig C. Synthesis and characterization of lanthanide [Ln(L)] 2 complexes of N 4O 3 amine phenol ligands with phenolate oxygen bridges: Evidence for very weak magnetic exchange between lanthanide ions Journal of the American Chemical Society. 114: 6081-6087.  1
1991 Berg DJ, Rettig SJ, Orvig C. Heptadentate Ligands for the Lanthanides. the First Structurally Characterized Example of a Lanthanide Heptadentate Ligand Complex: {Tris(3-aza-4-methyl-6-oxohept-4-en-1-yl)amine}ytterbium(III) Journal of the American Chemical Society. 113: 2528-2532.  1
1991 Liu S, Rettig SJ, Orvig C. Synthesis and characterization of a pentadentate schiff base N3O2 ligand and its neutral technetium(V) complex. X-ray structure of {N,N′-3-azapentane-1,5-diylbis(3-(1-iminoethyl)-6-methyl-2H-pyran-2,4(3H)- dionato)(3-)-O,O′,N,N′,N″}oxotechnetium(V) Inorganic Chemistry. 30: 4915-4919.  1
1991 Zhang Z, Rettig SJ, Orvig C. Lipophilic coordination compounds: Aluminum, gallium, and indium complexes of 1-aryl-3-hydroxy-2-methyl-4-pyridinones Inorganic Chemistry. 30: 509-515.  1
1990 Clevette DJ, Orvig C. Comparison of ligands of differing denticity and basicity for the in vivo chelation of aluminium and gallium Polyhedron. 9: 151-161. DOI: 10.1016/S0277-5387(00)80564-1  1
1990 Clevette DJ, Lyster DM, Nelson WO, Rihela T, Webb GA, Orvig C. Solution chemistry of gallium and indium 3-hydroxy-4-pyridinone complexes in vitro and in vivo Inorganic Chemistry. 29: 667-672.  1
1989 Lutz TG, Clevette DJ, Rettig SJ, Orvig C. Metal chelation with natural products: Isomaltol complexes of aluminum, gallium, and indium Inorganic Chemistry. 28: 715-719.  1
1989 Nelson WO, Rettig SJ, Orvig C. Aluminum and gallium complexes of 1-ethyl-3-hydroxy-2-methyl-4-pyridinone: A new exoclathrate matrix Inorganic Chemistry. 28: 3153-3157.  1
1989 Clevette DJ, Nelson WO, Nordin A, Orvig C, Sjöberg S. Complexation of aluminum with N-substituted 3-hydroxy-4-pyridinones Inorganic Chemistry. 28: 2079-2081.  1
1982 Jones AG, Davison A, LaTegola MR, Brodack JW, Orvig C, Sohn M, Toothaker AK, Lock CJ, Franklin KJ, Costello CE, Carr SA, Biemann K, Kaplan ML. Chemical and in vivo studies of the anion oxo[N,N'-ethylenebis(2-mercaptoacetimido)]Technetate(V). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 23: 801-9. PMID 7108629  1
1981 Cotton FA, Daniels L, Davison A, Orvig C. Structural characterization of the octachloroditechnetate(III) ion in its tetrabutylammonium salt Inorganic Chemistry. 20: 3051-3055. DOI: 10.1021/ic50223a058  0.56
1980 Jones AG, Orvig C, Trop HS, Davison A, Davis MA. A survey of reducing agents for the synthesis of tetraphenylarsonium oxotechnetiumbis(ethanedithiolate) from [99Tc] pertechnetate in aqueous solution. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 21: 279-81. PMID 7365521  0.56
1979 Wilson BW, Costello CE, Carr SA, Biemann K, Orvig C, Davison A, Jones AG. Field desorption mass spectrometry of complex anions containing rhenium and technetium Analytical Letters. 12: 303-311. DOI: 10.1080/00032717908082533  1
Show low-probability matches.